Royal Caribbean International sails 23 ships to more than 250 destinations around the world delivering the world’s best vacation for adventure seekers on the most innovative vessels at sea. The cruise line is launching a new brand campaign inviting these seekers to “Come Seek” their own experience filled with adventure, exploration and discovery.
“Come Seek” reflects the brand’s adventurous spirit by placing the traveler’s personal experience and point of view at the heart of the campaign. It also showcases the essence of the experience that the brand has been delivering for more than 40 years. Known for its innovation – including the revolutionary Oasis- and Quantum-class ships – and delivering many industry-firsts from ziplines and rock climbing walls, the FlowRider surf simulator and the RipCord by iFly skydiving experience, to leading technological breakthroughs like VOOM – the fastest internet at sea, Royal Caribbean continues to transform the cruise experience offering an active adventure with an immersive experience and connectivity that all travelers desire.
“Our mission is to challenge misperceptions and invite the next generation of travelers to experience the unique Royal Caribbean adventure,” said Michael Bayley, president & CEO, Royal Caribbean International. “Our loyal guests recognize that Royal Caribbean is an adventure designed to inspire and excite the senses. With our new campaign, we will show these new travelers what our guests already know and love.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7657051-royal-caribbean-come-seek/
She’s smart, fashionable, tech savvy and incredibly adventurous, and she’s poised to bring the cruise industry into the 21st century. Royal Caribbean International’s newest cruise ship Quantum of the Seas arrived into her homeport of Cape Liberty Cruise Port in Bayonne, NJ today, bringing with her a wave of unprecedented first-at-sea features and amenities. Superfast wireless connectivity, the world’s first robotic bartenders, a skydiving simulator, bumper cars, futuristic entertainment, and partnerships with celebrated chefs Jamie Oliver, Michael Schwartz and Devin Alexander, are just a small sample of what the modern age of cruising looks like onboard Quantum of the Seas.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7081453-quantum-of-the-seas-future-of-cruising-royal-caribbean/
Royal Caribbean Cruise owned by Royal Caribbean Cruises Ltd. This is the Norwegian and American cruise line based in Miami, Florida. Royal Caribbean Cruise provides the best facilities and services for visitors and staff.
Today, Royal Caribbean International recognizes an important milestone in its 45-year company history as it welcomes its 50 millionth guest onboard its fleet of 21 ships. The momentous occasion kicks off a year-long celebration honoring the cruise line’s guests, business partners, employees and crew.
“For more than 45 years, Royal Caribbean’s guiding principle has been to deliver the WOW to our guests, providing them with experiences, services and amenities that can only be found on Royal Caribbean,” said Adam Goldstein, President and CEO, Royal Caribbean International. “The men and women on our ships who deliver these WOW moments are what inspire our loyal guests to return to sail with us again and again.”
To view the Multimedia News Release, go to http://www.multivu.com/mnr/55592-royal-caribbean-celebrate-50-million-guests-countless-wows
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
RNIB -- I\'d miss -- World Book Day. To mark World Book Day, RNIB (The Royal National Institute of Blind people) has launched an online campaign to highlight the acute shortage of books accessible to blind and partially sighted people, especially children.
Have you ever considered what you would have missed out on if you weren\'t able to enter the magical world of children\'s stories?
RNIB needs your help to give children who have lost their sight the same reading opportunities this World Book Day.
Click here to get involved -- http://www.facebook.com/rnibuk
Philips Respironics, a unit of Royal Philips Electronics (NYSE: PHG, AEX: PHI) and a pioneer in science-based sleep solutions, is simplifying the design, fitting and care of full-face masks for sleep apnea patients. With its unique modular design, the new Amara full-face mask further demonstrates Philips’ commitment to developing solutions aimed at improving care and outcomes.
To view Multimedia News Release, go to http://www.multivu.com/mnr/57117-philips-respironics-revolutionary-full-face-mask-sleep-therapy
Ever wondered what happens behind the doors of one of the world’s most established venues? IFSEC Global.com has got a backstage pass to the Royal Albert Hall to investigate how it keeps world-famous performers, and this iconic building, safe and secure.
Speaking to Amanda Squires, Director of Operations, an insight is given to the co-ordination of the 850 events delivered each year, as well as, the delicate procedure undertaken for getting modern CCTV and access control systems in place in this grade 1 listed building.
Amanda is joining the Protecting London panel debate at IFSEC International 2015, 16 – 18 June at ExCeL London, along with the British Museums’ Health & Safety Manager and Crossrail Ltd.’s Security Manager to discuss the considerations that need to be made when protecting such high value assets.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7537851-protecting-london-royal-albert-hall/
Personalised Medicine is the future of cancer treatment, but it presents major challenges for doctors and health services, the President of the European Society of Medical Oncology has said. Professor Rolf Stahel was speaking ahead of the 3rd Astellas Innovation Debate: i-Genes – What the DNA and Data Revolutions mean for our Health, taking place on Thursday 29th January 2015 at the Royal Institution of Great Britain.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7430351-professor-rolf-stahel-astellas-debate/
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
